Amgen (AMGN) Tops Q3 EPS by 24c, FY Guidance Tops Views
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $269.38 -1.33%
Revenue Growth %: +22.5%
Financial Fact:
Interest expense, net: 325M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +22.5%
Financial Fact:
Interest expense, net: 325M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q3 EPS of $3.69, $0.24 better than the analyst estimate of $3.45. Revenue for the quarter came in at $5.9 billion versus the consensus estimate of $5.77 billion.
GUIDANCE:
Amgen sees FY2018 EPS of $14.00-$14.25, versus the consensus of $14.02. Amgen sees FY2018 revenue of $23.2-23.5 billion, versus the consensus of $23.17 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Business First Bancshares, Inc. (BFST) Misses Q1 EPS by 7c
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
